SCHEMBL8647232

SCHEMBL8647232

CCCCc1ccc(C(=O)n2c(C)c(CC(=O)O)c3cc(OC)ccc32)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.78
AKR1C2 P52895 6/20 0.78
AKR1C4 P17516 2/20 0.76
AKR1C1 Q04828 2/20 0.76
LMNA P02545 2/20 0.74
CYP1A2 P05177 2/20 0.74
CYP2D6 P10635 2/20 0.74
CYP2C9 P11712 2/20 0.74
HIF1A Q16665 2/20 0.74
NPSR1 Q6W5P4 2/20 0.74
TSHR P16473 1/20 0.74
NFKB1 P19838 1/20 0.74
PTGS2 P35354 4/20 0.73
KDM4E B2RXH2 1/20 0.73
MEN1 O00255 1/20 0.73
PTGES O14684 1/20 0.73
ABCC3 O15438 1/20 0.73
ABCC4 O15439 1/20 0.73
ABCB11 O95342 1/20 0.73
MT-CO2 P00403 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801150 0.91 AKR1C3 (0.87) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL18271385 0.90 AKR1C3 (0.82) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL24969415 0.90 AKR1C3 (0.67) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL19861551 0.89 AKR1C3 (0.74) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL8645594 0.88 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL5646082 0.88 AKR1C3 (0.76) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL5646126 0.87 LMNA (0.76) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL14886867 0.87 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL14351102 0.87 AKR1C3 (0.83) AKR1C3AKR1C2AKR1C4AKR1C1LMNA
SCHEMBL5645861 0.86 AKR1C3 (0.76) AKR1C3AKR1C2AKR1C4AKR1C1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0746544-B1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMA INC (US) 1998-09-09 EP disclosed